In previous studies, the author has reported both in vitro and in vivo sleep studies in which there were complex interactions between benzodiazepine hypnotics and the dihydropyridine calcium channel blocker nifedipine. The author has also reported that microinjections of triazolam into the dorsal raphe nucleus of the rat result in enhancement of wakefulness. In the present study, nifedipine and triazolam were coadministered into this site. As previously was observed, triazolam produced a dose-dependent increase in sleep latency and a decrease in 
total sleep, primarily by reducing non-rapid-eye movement sleep. Nifedipine had no effect on sleep when given by itself but prevented the alterations in sleep by triazolam. These various sleep effects were not associated with alterations in core temperature. These data are consistent with the view that some aspect of the sleep altering activity of triazolam involves interaction with voltage-dependent calcium channel activity. [Neuropsychopharmacology 10:151-155, 1994J been reported to prevent alterations in uptake of cal cium into synaptosomes induced by micromolar con centrations of diazepam (Mendelson et al. 1984) . One implication of this work may be that the mechanism by which BZs enhance sleep may involve alteration of some subclass of voltage-dependent calcium channels.
To explore this phenomenon further, we have now ad ministered nifedipine in conjunction with triazolam at a eNS site at which microinjection of triazolam has been reported to reduce total sleep and enhance wakefulness, the dorsal raphe nucleus (Mendelson et al. 1987) .
MATERIALS AND METHODS

Animals and Animal Care
The studies were performed on 13 male Sprague Dawley albino rats weighing between 250 and 300 g pur chased from Taconic Farms (Germantown, NY). After the surgical implantation of cannulae and electrodes (Mendelson et al. 1974) , the rats were housed individ ually in smooth-walled plastic cages for at least 1 week prior to use in a study. The rats were housed the night 0893-133X/94/$7.00 before an experiment in the chambers in which they would subsequently be tested. Lights were on from 8:00 AM until 8:00 PM.
Placement of Cannulae and Electrodes
Each rat was anesthetized with 70 mg/kg ketamine and 6 mg/kg xylazine administered intramuscularly. The rat was then mounted in a Kopf stereotactic apparatus. Af ter a scalp incision was made and the skull exposed, a hole was drilled at a stereotactically determined loca tion. The dura was then gently disrupted at the hole and a 24-gauge stainless-steel guide cannula was low ered to 1.0 mm above the dorsal raphe. The stereotac tic coordinates of the top of the guide cannula, derived originally from Paxinos and Watson (1986) and assessed from previous work and pilot studies, were as follows: -8.4 mm anteroposterior, -4.3 dorsoventral, 1.5 mm mediolateral (the latter placed at an angle of 20° from vertical to the skull in the coronal plane).
During the same surgical procedure, four 0-80 stainless-steel screws were implanted through the skull to serve as dural EEG electrodes. These screws were connected to an Amphenol socket by short lengths of 0.010-inch Teflon-coated stainless-steel wire. The stripped ends of two other lengths of this wire were implanted in the neck musculature to act as electromyo graphic (EMG) electrodes and these, too, were con nected to the Amphenol socket. Before releasing the rat from the stereotactic apparatus, the entire assem bly of cannulae, electrodes, and Amphenol socket was cemented in place with dental acrylic.
Intracranial Injections
In this study, each animal received all six drug and ve hicle combinations. Treatments were given on the ba sis of a modifIed Latin Square design, with studies sepa rated by 1 week each. At 10:00 AM the morning of an experiment, an injection cannula of 31-gauge stainless steel tubing was inserted so that the tip extended pre cisely 1.0 mm past the tip of the guide cannula into the brain. The drug or vehicle (fIrst warmed to 37°q was injected from a 10-l.ll Hamilton syringe through a length of PE 20 tubing attached to the injection cannula. The injection was made at a rate of 0.2 I.lllmin, for a total volume of 0.41.l1, using a syringe pump, and the inner cannula was left in place for 30 seconds after each in jection. In all cases, triazolam or its vehicle was given fIrst, followed 5 minutes later by nifedipine or its ve hicle.
Triazolam was dissolved in a 1:1 mixture of Emul ph or polyoxyethylated vegetable oil and ethanol. Just prior to the injection, this solution was diluted 10-fold with artifIcial cerebrospinal fluid (0.5 mM NaH2P04, 0.25 mM Na2HP04, 0.4 mM MgCh, 0.65 mM CaCh, NEUROPSYCHOPHARMACOLOGY 1994-VOL. 10, NO.3 3 mM KCl, 128 mM NaCl, 25 mM NaHC03, and 250 mg/ml bovine serum albumin, pH = 7.4). The two doses given were 0.251.lg (0.73 nmollL) and 0.51.lg (1.46 nmoIlL). Nifedipine was prepared by dissolving 40 mg (115 I.lmollL) in 300 I.ll of distilled water and injected for a total dose of 16 I.lg (46 nmoIlL).
Electroencephalographic Recordings
Following the injection of the drugs, each rat was placed back in its testing chamber and a cable to a Grass Model 78 polygraph was attached to the Amphenol connec tor on the rat's headset. Three traces representing bifrontal EEG frontooccipital EEG, and EMG were recorded for 2 hours for each rat. The paper speed was 10 mm/sec and the vertical deflection of the pen was calibrated so that 1.0 cm signifIed an electrical poten tial of 50 I.lV.
After the 8-hour recording session, each rat was returned to individual housing, and subsequent tests of further drug treatment conditions were performed at weekly intervals, such that all animals received all treatments. The order of treatment administration was determined by randomly assigning each rat to one of six treatment sequences. At the end of the study, an analysis of variance was performed in which "sequence" was an independent variable and it was confIrmed that it had no signifIcant effect on sleep variables such as sleep latency and total sleep time.
At the end of the study, a single investigator (who was unaware of the treatment condition) classifIed each 30-second epoch as "waking," "non-rapid-eye-move ment (non-REM) sleep," or "REM sleep" (Mendelson et al. 1974 (Mendelson et al. , 1978 . The results were then tallied and 
Measurement of Core Body Temperature
The serotonergic system is involved in temperature regulation and, in turn, temperature regulation may have important effects on sleep (Nagel and Satinoff 1980; Szymusiak and Satinoff 1984) . Thus, to examine the possibility that any drug effects on sleep are in directly mediated by alterations in temperature, we have also followed core temperature using the Mini Mitter system that includes a transmitter which is im planted intraperitoneally in the rat at the time of the surgical placement of the EEG electrodes. This trans mitter sends out a signal that encodes temperature. A receiver is situated underneath each of the testing cages, and the signal is decoded at a personal computer. Thus, body temperature can be monitored on a constant ba sis in a freely moving animal.
Histological Examination of Injection Accuracy
After a rat completed all the weekly drug treatments and EEG recordings for a given experimental protocol, an injection of 400 mg/kg of sodium pentobarbital was given intraperitoneally, and the animal was perfused transcardially with 0.9% NaCl followed by 4% forma lin in 1.25% NaCl. The rat was decapitated, and the brain was removed and stored in the formalin solution.
Brain sections (48-!lm thick) were cut on a freezing mi crotome, mounted on slides, and stained with cresyl 
RESULTS
Sleep Variables
As seen in Table 1 
Core Temperature
A series of variables were examined, including base line (30 minutes before injection), mean for the first hour, mean for 6 hours, the difference between the baseline and the mean for the 1st hour, the highest tem perature in 6 hours, and time from injection until the highest temperature was reached. For two animals, there were technical difficulties with temperature data; values for the remaining 11 animals are found in Table   2 . There were no signiflcant drug effects on any tem perature measure. Also shown Table 2 are the mean values for the ambient temperature, which was not signifIcantly different across treatments.
CONCLUSIONS
These data conflrm previous work (Mendelson et a1. 1987) , which indicated that microinjections of triazo lam decrease total sleep time, primarily by decreasing non-REM sleep. They are consistent with previous reports of increased motor activity after injections of benzodiazepines into the median raphe (Sainati and Lo rens 1982) . Systematic injections of benzodiazepines Mendelson et al. (1978) .
triaz .25 + triaz .5 + nifed nifed AN OVA 27.5 ± 4.011 29.5 ± 3.7** 0.001 62.5 ± 4.4 64.4 ± 2.7 § 0.03 3.3 ± .82 3.8 ± 0.8 NS 58.9 ± 4.2 60.2 ± 2.9** 0.01 44.6 ± 10.5 38.7 ± 9.5 NS 31.6 ± 3.8 27.9 ± 3.2 NS Abbreviations: triaz .25 = triazolam .25 Ilg; triaz .5 = triazolam .5 Ilg; nifed = nifedepine 16 Ilg; NS = not statistically significant; ANOVA = analysis of variance. All values represent mean ± SEM minutes. have been reported to decrease serotonin turnover in the dorsal raphe and various projection sites (Nishikawa and Scatton 1985) and to potentiate the inhibitory effects of gamma-aminobutyric acid on neuronal fIring on the dorsal raphe (Gallagher 1978) . Insofar as electrolytic le sions of the dorsal raphe (Jouvet and Renault, 1966) We have previously reported that nifedipine ad- mi nistered intraventricularly blocks sleep induction by fl urazepam injected systemically (Mendelson et al. 1984) and that comicroinjection of nifedipine into the medial preoptic area prevents sleep enhancement by triazo lam injected locally (Mendelson and Monti 1992) .
Voltage-dependent calcium channels are found in many excitable tissues (Reborn and Gonzales 1988) and may be involved in various functions including pacemak ing in autorhythmic cells. Binding sites for dihydropyri dines such as nifedipine, which may be markers of one class of these channels, are found regionally in the cen tral nervous system on neuronal cell bodies (Sanna and Hanbauer 1986) . Calcium channels have been linked to central benzodiazepine receptors (Hirsch and Kochran, 1982) , and the affinity of some benzodiaze pines to the type II receptor has been reported but not yet confIrmed to be sensitive to calcium ion concentra ti ons (Lo et al. 1983 ). The present sleep study and the two previous reports on systemic flurazepam and tria zolam microinjected into the medial preoptic area sup port the view that the mechanism by which these ben zodiazepines alter sleep may involve alterations in voltage-dependent calcium channel function.
